Carina Biotech
Rohina Batra is the Founder and Director of CFO Plus, a financial advisory firm specializing in providing outsourced finance functions for tech start-ups. Rohina also serves as the CFO for multiple companies in various industries, including Regrow Ag, ENA Respiratory Pty Ltd, Carina Biotech, Aravax, and Lawpath. Batra previously held the position of Director at Fuschia Careers, a recruitment and executive search firm. Rohina holds a BA in Economics (Hons.) from Delhi University and a GAICD from the Australian Institute of Company Directors. Additionally, Rohina has a degree in Front End Web Development from General Assembly.
Carina Biotech
Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.